+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nucleic Acid Amplification Testing Market by Technology, Product Type, End User, Application - Global Forecast to 2030- Product Image
Nucleic Acid Amplification Testing Market by Technology, Product Type, End User, Application - Global Forecast to 2030- Product Image
Sale

Nucleic Acid Amplification Testing Market by Technology, Product Type, End User, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5460252
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Nucleic Acid Amplification Testing Market is evolving rapidly, with sustained innovation driving adoption across clinical and research sectors. Uptake is fueled by demand for faster, more precise diagnostics and solutions that support both centralized laboratories and point-of-care testing environments.

Market Snapshot: Nucleic Acid Amplification Testing

In 2024, the Nucleic Acid Amplification Testing Market reached USD 3.53 billion and is anticipated to climb to USD 4.00 billion by 2025. The sector is forecast to expand at a compound annual growth rate (CAGR) of 12.90%, attaining USD 7.31 billion by 2030. Market momentum is supported by breakthroughs in amplification chemistries, integration of digital platforms, and expanding demand for decentralized testing capabilities.

Scope & Segmentation

  • Technology – Includes isothermal amplification (helicase dependent amplification, loop mediated amplification, nucleic acid sequence-based amplification, strand displacement amplification, transcription mediated amplification) and polymerase chain reaction (digital polymerase chain reaction, real-time polymerase chain reaction).
  • Product Types – Encompasses instruments (benchtop, portable), reagents & kits (buffers, enzymes, master mixes, primers & probes), and software & services (data analysis software, maintenance & support, training & consulting services).
  • End Users – Diagnostic laboratories, hospitals, point of care testing centers, and research institutes utilize these solutions for varied diagnostic and research activities.
  • Applications – Spans companion diagnostics, genetic testing (carrier screening, prenatal testing, rare disease diagnostics), infectious disease (bacterial, parasitic, viral), and oncology (biomarker testing, minimal residual disease detection, mutation analysis).
  • Regions – Coverage across Americas (United States with state-level granularity, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including key countries in Western Europe, Eastern Europe, Middle East, and Africa), and Asia-Pacific (notably China, India, Japan, Australia, South Korea, Southeast Asia, among others).
  • Key Companies – Roche Holding AG, Abbott Laboratories, QIAGEN N.V., Thermo Fisher Scientific Inc., Danaher Corporation, bioMérieux SA, Hologic Inc., Siemens Healthineers AG, Becton, Dickinson and Company, PerkinElmer Inc.

Key Takeaways for Senior Decision-Makers

  • Nucleic acid amplification testing is reshaping modern diagnostics by enabling rapid, highly sensitive detection of genetic material—significantly enhancing clinical decision-making.
  • Advancements such as digital PCR and isothermal amplification enable multi-target detection and quantitative analysis, supporting applications from infectious disease surveillance to oncology profiling.
  • Integration of automated sample preparation and digital platforms streamlines workflows, reducing the need for extensive manual intervention and facilitating broader access, even in decentralized or resource-limited settings.
  • Collaboration with reagent suppliers and modular instrument designs are strengthening supply chain resilience and flexibility, promoting sustainable regional growth and operational agility.
  • Competitive differentiation is achieved through strategic alliances, technology transfer, and targeted acquisitions, allowing both large and nimble firms to address emerging niches and regulatory requirements efficiently.

Tariff Impact: Navigating 2025 Regulatory Changes

Changes in US tariffs initiated in 2025 have increased complexities for the supply chain, specifically affecting imported reagents, instruments, and essential consumables. Market participants are responding by increasing domestic production, diversifying sourcing, and adjusting pricing structures. Regulatory bodies are accelerating review pathways for domestically manufactured products and incentivizing innovation through policy adjustments, all aimed at supporting market stability and cost management.

Research Methodology & Data Sources

This report leverages secondary research from peer-reviewed journals, regulatory filings, white papers, and corporate disclosures. Primary insights originate from interviews with subject matter experts, ensuring both topical depth and operational nuance. Rigorous data triangulation validates trends and reconciles expert viewpoints, with quality control throughout to maintain accuracy and reliability.

Why This Report Matters

  • Offers a structured, data-driven view into current and emerging trends for the nucleic acid amplification testing market, aiding executives in prioritizing strategic investments.
  • Supports operational planning by clarifying the impact of regulatory and supply chain dynamics on technology adoption and competitive positioning.
  • Enables stakeholders to identify high-potential growth segments and develop tailored, region-specific market entry and expansion strategies.

Conclusion

Senior leaders using this report gain actionable intelligence for technology, supply chain, and regional planning decisions. The analysis delivers clear guidance for navigating a rapidly changing diagnostic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Nucleic Acid Amplification Testing Market, by Technology
8.1. Introduction
8.2. Isothermal Amplification
8.2.1. Helicase Dependent Amplification
8.2.2. Loop Mediated Amplification
8.2.3. Nucleic Acid Sequence Based Amplification
8.2.4. Strand Displacement Amplification
8.2.5. Transcription Mediated Amplification
8.3. Polymerase Chain Reaction
8.3.1. Digital Polymerase Chain Reaction
8.3.2. Real Time Polymerase Chain Reaction
9. Nucleic Acid Amplification Testing Market, by Product Type
9.1. Introduction
9.2. Instruments
9.2.1. Benchtop Instruments
9.2.2. Portable Instruments
9.3. Reagents & Kits
9.3.1. Buffers
9.3.2. Enzymes
9.3.3. Master Mixes
9.3.4. Primers & Probes
9.4. Software & Services
9.4.1. Data Analysis Software
9.4.2. Maintenance & Support
9.4.3. Training & Consulting Services
10. Nucleic Acid Amplification Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Point of Care Testing
10.5. Research Institutes
11. Nucleic Acid Amplification Testing Market, by Application
11.1. Introduction
11.2. Companion Diagnostics
11.3. Genetic Testing
11.3.1. Carrier Screening
11.3.2. Prenatal Genetic Testing
11.3.3. Rare Disease Diagnostics
11.4. Infectious Disease
11.4.1. Bacterial Infectious Disease
11.4.2. Parasitic Infectious Disease
11.4.3. Viral Infectious Disease
11.5. Oncology
11.5.1. Biomarker Testing
11.5.2. Minimal Residual Disease Detection
11.5.3. Mutation Analysis
12. Americas Nucleic Acid Amplification Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Nucleic Acid Amplification Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Nucleic Acid Amplification Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Holding AG
15.3.2. Abbott Laboratories
15.3.3. QIAGEN N.V.
15.3.4. Thermo Fisher Scientific Inc.
15.3.5. Danaher Corporation
15.3.6. bioMérieux SA
15.3.7. Hologic, Inc.
15.3.8. Siemens Healthineers AG
15.3.9. Becton, Dickinson and Company
15.3.10. PerkinElmer, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. NUCLEIC ACID AMPLIFICATION TESTING MARKET MULTI-CURRENCY
FIGURE 2. NUCLEIC ACID AMPLIFICATION TESTING MARKET MULTI-LANGUAGE
FIGURE 3. NUCLEIC ACID AMPLIFICATION TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. NUCLEIC ACID AMPLIFICATION TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. NUCLEIC ACID AMPLIFICATION TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NUCLEIC ACID AMPLIFICATION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HELICASE DEPENDENT AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY LOOP MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STRAND DISPLACEMENT AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRANSCRIPTION MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIGITAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BENCHTOP INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PORTABLE INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRIMERS & PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY CARRIER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRENATAL GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY RARE DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BACTERIAL INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PARASITIC INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY VIRAL INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MINIMAL RESIDUAL DISEASE DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY MUTATION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 82. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 84. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 85. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 87. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 88. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 89. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 92. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 93. CANADA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 94. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 96. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 97. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 100. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 101. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 104. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 105. MEXICO NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 154. UNITED KINGDOM NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 155. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 157. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 158. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 160. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 161. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 162. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 165. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 166. GERMANY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 167. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 169. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 170. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 172. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 173. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 174. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 177. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 178. FRANCE NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 184. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 185. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 186. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 189. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 191. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 192. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 193. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 194. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 197. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 198. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 199. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 201. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 202. ITALY NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 203. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 204. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 205. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 208. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 213. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 214. SPAIN NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 232. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 234. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 244. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 251. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 253. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 254. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 256. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 257. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 258. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 261. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 262. DENMARK NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 270. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 273. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 274. NETHERLANDS NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 275. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, 2018-2030 (USD MILLION)
TABLE 277. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2030 (USD MILLION)
TABLE 278. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 279. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 280. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 281. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2030 (USD MILLION)
TABLE 282. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 284. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY GENETIC TESTING, 2018-2030 (USD MILLION)
TABLE 285. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 286. QATAR NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 287. FINLAND NUCLEIC ACID AMPLIFICATION TESTING MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Nucleic Acid Amplification Testing market report include:
  • Roche Holding AG
  • Abbott Laboratories
  • QIAGEN N.V.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • bioMérieux SA
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 4 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.31 Billion
Compound Annual Growth Rate12.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Isothermal Nucleic Acid Amplification Technology Market by Product Type, Workflow, Platform, Technology, End User, Application - Global Forecast to 2030 - Product Image

Isothermal Nucleic Acid Amplification Technology Market by Product Type, Workflow, Platform, Technology, End User, Application - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Nucleic Acid Amplification Testing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F - Product Image

Nucleic Acid Amplification Testing Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Nucleic Acid Amplification Testing Market Report 2025 - Product Image

Nucleic Acid Amplification Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2025-2033 - Product Image

Isothermal Nucleic Acid Amplification Technology Market Size, Share, Trends and Forecast by Product, Technology, Application, End-User, and Region, 2025-2033

  • Report
  • 139 Pages
  • Global
From
Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Strategic Business Report - Product Image

Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From

About the Nucleic Acid Amplification Test Market

The Nucleic Acid Amplification Test (NAAT) market is a segment of the In Vitro Diagnostics (IVD) industry. NAATs are used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. These tests are used to diagnose and monitor a wide range of infectious diseases, including HIV, hepatitis, and tuberculosis. NAATs are also used to detect genetic mutations associated with cancer and other inherited diseases. NAATs are highly sensitive and specific, and can be used to detect very small amounts of nucleic acid. This makes them ideal for use in clinical settings, where rapid and accurate diagnosis is essential. NAATs are also used in research and public health settings, where they can be used to monitor the spread of infectious diseases. The NAAT market is highly competitive, with many companies offering a range of products. Some of the major players in the market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Cepheid, and Hologic. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.